mRNA-1647: Clinical Trials

3 completed, 1 active not recruiting, 1 withdrawn. 5 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	5	Completed 3, Active not recruiting 1, Withdrawn 1
Phase 1	1	Completed 1

Follow mRNA-1647: new trials by email Literature Review of mRNA-1647 trials Research Report on mRNA-1647

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients mRNA-1647, Placebo - Cytomegalovirus Infection	Phase 2	Withdrawn	ModernaTX, Inc.		2024-02-08	2024-03-15
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants. mRNA-1647, Placebo - Cytomegalovirus Infection	Phase 2	Active not recruiting	ModernaTX, Inc.	84	2023-04-05	2026-08-10
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age mRNA-1647, Placebo - Cytomegalovirus	Phase 1 / Phase 2	Completed	ModernaTX, Inc.	873	2022-11-07	2026-06-04
A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine mRNA-1647 - Cytomegalovirus Infection	Phase 2	Completed	ModernaTX, Inc.	135	2021-06-18	2026-02-02
Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults mRNA-1647, Placebo - Cytomegalovirus Infection	Phase 2	Completed	ModernaTX, Inc.	315	2020-01-09	2026-05-05

Conditions studied

Cytomegalovirus Infections (4)  ·  DNA Virus Infections (4)  ·  Virus Diseases (4)  ·  Herpes Simplex (2)

Sponsors

ModernaTX, Inc. (5)

Countries

United States (4)  ·  Canada (1)  ·  United Kingdom (1)

Results publications

PMID 38190492